TIFFANIE WOJNO: Open Payments
NPI 1801525399 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 128 payments from 11 companies in 2025. Trend: 2023 $845 · 2024 $1,399 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $307 |
| Amgen Inc. | 22 | $224 |
| HEARTFLOW, INC. | 12 | $216 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $148 |
| Novo Nordisk Inc | 10 | $137 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 15 | $130 |
| Impulse Dynamics (USA) Inc. | 3 | $95 |
| Esperion Therapeutics, Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: LEQVIO, REPATHA, FFRct, JARDIANCE, Kerendia, LifeVest, Wegovy, Optimizer.
Industry payments across PA — which companies pay providers there.
